About Venomtech
Venomtech is a company based in Sandwich (United Kingdom) founded in 2010. Venomtech has raised $1.36 million across 4 funding rounds. The company has 6 employees as of February 28, 2023. Venomtech operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Sandwich, United Kingdom
- Employees 6 as on 28 Feb, 2023
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Venomtech Limited
- Date of Incorporation 16 Mar, 2010
- Jurisdiction SANDWICH, KENT, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.36 M (USD)
in 4 rounds
-
Latest Funding Round
$395.25 K (USD), Seed
Sep 10, 2021
-
Investors
-
Employee Count
6
as on Feb 28, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Venomtech
Venomtech has successfully raised a total of $1.36M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $395.25 thousand completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Seed — $395,249
-
First Round
First Round
(01 Aug 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Seed - Venomtech | Valuation |
investors |
|
| Mar, 2015 | Amount | Seed - Venomtech | Valuation |
investors |
|
| Apr, 2014 | Amount | Seed - Venomtech | Valuation |
investors |
|
Investments & Acquisitions by Venomtech
Financial Statements - Venomtech
Venomtech Comparisons
Competitors of Venomtech
Venomtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Latest news on Venomtech
Frequently Asked Questions about Venomtech
Venomtech was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Venomtech is headquartered in Sandwich, United Kingdom.
Venomtech is a funded company, having raised a total of $1.36M across 4 funding rounds to date. The company's 1st funding round was a Seed of $252.5K, raised on Aug 01, 2013.
As of Feb 28, 2023, the latest employee count at Venomtech is 6.
Venomtech was founded in 2010 in Sandwich, United Kingdom, within the bioprospecting and biological research sector. Compound libraries of animal venoms are supplied for hit-to-tool screening and biotherapeutic development. Molecular biology and biological safety consultancy, along with education, are offered. Targeted Venom Discovery Arrays (TVDAs), custom libraries of peptide proteins, and venom components are provided, including hit-to-lead services for drug discovery.
Venomtech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.